View in EDS HTML Full Text PDF Full Text

Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.

Saved in:
Bibliographic Details
Title: Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
Authors: Kumar S; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia. shejil.kumar@health.nsw.gov.au.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia. shejil.kumar@health.nsw.gov.au.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia. shejil.kumar@health.nsw.gov.au., Gild ML; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia., McDonald MM; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia., Kim AS; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia., Clifton-Bligh RJ; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia., Girgis CM; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.
Source: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Oct; Vol. 35 (10), pp. 1871-1872. Date of Electronic Publication: 2024 Aug 09.
Publication Type: Letter; Comment
Journal Info: Publisher: Springer International Country of Publication: England NLM ID: 9100105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2965 (Electronic) Linking ISSN: 0937941X NLM ISO Abbreviation: Osteoporos Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39120625
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia. shejil.kumar@health.nsw.gov.au.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia. shejil.kumar@health.nsw.gov.au.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia. shejil.kumar@health.nsw.gov.au.<br /><searchLink fieldCode="AU" term="%22Gild+ML%22">Gild ML</searchLink>; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22McDonald+MM%22">McDonald MM</searchLink>; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Kim+AS%22">Kim AS</searchLink>; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, Australia.; Bone Biology Program, Garvan Institute of Medical Research, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Clifton-Bligh+RJ%22">Clifton-Bligh RJ</searchLink>; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.; Department of Diabetes & Endocrinology, Royal North Shore Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Girgis+CM%22">Girgis CM</searchLink>; Department of Diabetes & Endocrinology, Westmead Hospital, Westmead Hospital, Cnr Hawkesbury Rd and Darcy Rd, Sydney, 2145 NSW, Australia.; Faculty of Medicine & Health, University of Sydney, Sydney, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229100105%22">Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</searchLink> [Osteoporos Int] 2024 Oct; Vol. 35 (10), pp. 1871-1872. <i>Date of Electronic Publication: </i>2024 Aug 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9100105 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1433-2965 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220937941X%22">0937941X </searchLink><i>NLM ISO Abbreviation: </i>Osteoporos Int <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39120625
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00198-024-07214-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1871
    Titles:
      – TitleFull: Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kumar S
      – PersonEntity:
          Name:
            NameFull: Gild ML
      – PersonEntity:
          Name:
            NameFull: McDonald MM
      – PersonEntity:
          Name:
            NameFull: Kim AS
      – PersonEntity:
          Name:
            NameFull: Clifton-Bligh RJ
      – PersonEntity:
          Name:
            NameFull: Girgis CM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1433-2965
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
              Type: main
ResultId 1